They may decrease CD14 receptor‐mediated endocytosis, reduce the effective presentation of autoantigens to T cells by downregulating CD80 and HLA‐DR, and diminish the production of inflammatory cytokines, thereby preventing or alleviating autoimmune diseases such as RA. The gene discussed is CD80; the disease is autoimmune disease.